BBUS ETF Analysis: JPMorgan BetaBuilders U.S. | BATS
Large Blend | BATS, USA | Market Cap: 8.664m USD | 12M Return: 23.3% | US46641Q3992 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 24.5M
Warnings
Tailwinds
No distinct edge detected
Seasonality 7.4 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
The JPMorgan BetaBuilders U.S. Equity ETF (BBUS) is a passively managed exchange-traded fund that tracks a free float adjusted, market capitalization weighted index of U.S. equity securities. The underlying index is designed to capture approximately 85% of the U.S. equity market by market capitalization, primarily focusing on large- and mid-cap companies. To maintain index alignment, the fund commits to investing at least 80% of its assets in securities held within the underlying index, making it a broad-market core equity exposure vehicle.
As part of JPMorgans BetaBuilders suite, the fund emphasizes beta exposure-aiming to replicate broad market performance rather than outperform it-using a transparent, rules-based methodology that excludes shares not available for public trading (insider holdings, government stakes, etc.) through its free float adjustment. Categorized within the Large Blend segment, BBUS blends large-cap stocks across both growth and value styles, offering investors diversified, low-turnover core U.S. equity exposure through a single ticker.
- Fed rate cut cycle boosts large-cap equity valuations
- Mega-cap technology concentration drives index performance
- ETF fee competition pressures expense margins lower
As of August 06, 2026, the stock is trading at USD 138.77 with a total of 285,592 shares traded. Over the past week, the price has changed by +5.60%, over one month by +2.46%, over three months by +6.69% and over the past year by +23.28%.
Current recommended Stop Loss: 135.00 (which is 2.7% or 2.2 ATR below the current price).
JPMorgan BetaBuilders U.S. has no consensus analysts rating.